Analysis Of Income And Expense [Abstract]

Embla Medical hf - Filing #5889952

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
854,889,000 USD
785,683,000 USD
Material income and expense [abstract]
Research and development expense
40,832,000 USD
38,142,000 USD
Finance income (cost)
25,930,000 USD
16,778,000 USD
Other operating income (expense)
399,000 USD
1,927,000 USD
Selling, general and administrative expense [abstract]
General and administrative expense
69,964,000 USD
66,891,000 USD
Sales and marketing expense
311,151,000 USD
293,080,000 USD
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
12,860,000 USD
12,860,000 USD
12,860,000 USD
5,866,000 USD
5,866,000 USD
5,866,000 USD
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates accounted for using equity method
3,340,000 USD
3,398,000 USD
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss
2,073,000 USD
811,000 USD
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
682,000 USD
0 USD
57,632,000 USD
0 USD
11,328,000 USD
68,278,000 USD
56,950,000 USD
0 USD
65,507,000 USD
412,000 USD
58,389,000 USD
0 USD
65,095,000 USD
6,706,000 USD
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
56,950,000 USD
65,095,000 USD
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
682,000 USD
412,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.